Knowledge Center

Patent / Dec 24, 2020

Continuous process for the preparation of anticholinergic drugs

Authors:
  • Marianna Katz
  • Nuno Torres
Source:
WO 2020254791

The present invention relates to a novel process for the preparation of anticholinergic agents/drugs, such as umeclidinium bromide, tiotropium bromide, glycopyrronium bromide, aclidinium bromide, ipratropium bromide (V) in continuous flow mode in the presence of one or more polar protic solvents. The anticholinergic drugs are in a form suitable for use in inhalation in the treatment of respiratory diseases such as asthma or chronic obstructive pulmonary disease (COPD).

Also in the Knowledge Center

Related Content

·¡±è¾±»å±ð±ôâ„¢

·¡±è¾±»å±ð±ôâ„¢ is an innovative technology with the ability to deliver sustained-release pharmaceuticals via surface erosion resulting in the ability to precisely tune pharmacokinetics to meet the target indication needs.

Page
Read more

Virtual Tours

Our doors are open. Welcome to our facilities. We are a Contract Development and Manufacturing Company dedicated to helping Pharmaceutical Customers bring new and off-patent drugs to market.

Page
Read more

Particle Engineering for Inhalation and Nasal

ËÄÉ«AV is a global expert and recognized leader in particle engineering, an essential technology when developing inhalation drug products.

Page
Read more